← Open Payments lookup

SHARON GIORDANI: Open Payments

NPI 1720201965 · QUINCY, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$522 in 28 payments from 11 companies in 2025. Trend: 2023 $322 · 2024 $472 · 2025 $522

Food & beverage: $522
CompanyPaymentsAmount
Amgen Inc.10$153
Novo Nordisk Inc4$75
Organon LLC2$55
UCB, Inc.2$49
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$39
GlaxoSmithKline, LLC.2$34
Currax Pharmaceuticals LLC2$32
Janssen Biotech, Inc.1$30
Lilly USA, LLC1$20
ANI Pharmaceuticals, Inc.1$20

Products named: OTEZLA, HADLIMA, Wegovy, Bimzelx, XIFAXAN, BENLYSTA, CONTRAVE, TREMFYA.

Industry payments across MA — which companies pay providers there.